Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 3.6B | 4.1B | 4.0B | 4.0B |
Cost of revenue | 3.0B | 3.5B | 3.4B | 3.4B |
Gross profit | 607M | 671M | 643M | 626M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 406M | 418M | 395M | 394M |
Other operating expenses | — | — | — | — |
Operating income | 194M | 246M | 241M | 225M |
Non operating interest income | ||||
Income | 32M | 0 | 6M | — |
Expense | 77M | 83M | 92M | 100M |
Other income expense | -10M | -383M | 24M | -95M |
Pretax income | 139M | -219M | 179M | 30M |
Tax provision | 43M | 95M | 45M | -206M |
Net income | 79M | -390M | 114M | 225M |
Basic EPS | 1.3 | -7.1 | 2.0 | 4.0 |
Diluted EPS | 1.3 | -7.1 | 2 | 4.0 |
Basic average shares | 55.6M | 55.4M | 55.2M | 54.9M |
Diluted average shares | 55.8M | 55.4M | 55.2M | 55M |
EBITDA | 309M | 331M | 326M | 306M |
Net income from continuing op. | 79M | -390M | 114M | 224M |
Minority interests | -7M | -2M | -5M | -6M |
Preferred stock dividends | — | — | — | — |